Clinical trial Recruiting at 1 site Interventional Ages 45 to 75

Multilevel approach to boost follow-up colonoscopy after abnormal FIT

Official title: PROACT: Promoting Follow-Up of Abnormal Colorectal Cancer Screening Tests Through Multilevel Interventions

Run by Fred Hutchinson Cancer Center · NCT06822530 · Data updated 2026-11-12

This trial tests a multilevel program to help people with abnormal FIT results complete a follow-up colonoscopy.

Quick facts

Study typeInterventional
Ages45 Years to 75 Years
SexAll
Enrollment682 (estimated)
SponsorFred Hutchinson Cancer Center
Academic / other
Locations1 site (Seattle, Washington)
StatusRecruiting
StartedDecember 16, 2025
Main results expectedJanuary 31, 2030
Study endsJanuary 31, 2030
Registry record updatedJune 22, 2026
Trial IDNCT06822530 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 45-75 who had an abnormal FIT, are enrolled at the specified UW/Fred Hutch clinics, and have not yet had a colonoscopy.

Probably not a fit

Patients unable to access rideshare services or who do not respond to educational materials may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests a multilevel intervention aimed at increasing follow-up colonoscopy after an abnormal FIT result. Participants are adults 45 to 75 receiving care at specified UW/Fred Hutch clinics and who have had an abnormal FIT but not yet completed colonoscopy. They are randomized to usual care with a CRC screening navigator versus usual care plus a patient-facing video and transportation assistance to address common barriers. The intervention includes a patient navigator, an educational video delivered via QR code or link, and rideshare transportation after colonoscopy, with 18 months of follow-up after the intervention. Outcomes focus on the rate of completed colonoscopy and related process measures across groups.

Why it matters

Potential benefit: If successful, the program could increase timely follow-up colonoscopies after abnormal FITs, potentially improving CRC detection.

How similar studies have gone: Prior studies with navigator support and patient education have shown improvements in follow-up after abnormal CRC screening tests, but the added transport and quick-response video are being tested here.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* PATIENTS: Age \>= 45 years old and =\< 75 years old
* PATIENTS: Receives care at an Harborview Medical Center (HMC) or University of Washington-Kent-Des Moines (UW-KDM) or University of Washington- Federal Way (UW-Federal Way) primary care clinic
* PATIENTS: \>= 1 month from documented abnormal FIT result
* PATIENTS: Has not received a colonoscopy between the abnormal FIT and enrollment
* CLINIC STAFF: HMC, UW-Federal Way, or UW-KDM physician or staff member who provides primary care or gastroenterology care
* CLINIC STAFF: Staff in the Fred Hutchinson (Fred Hutch)/UW Medicine Population Health Program that provide colorectal cancer screening and navigation

Where it's running

  • Fred Hutch/University of Washington Cancer Consortium
    Seattle, Washington, United States
    Recruiting

Study contacts

  • Principal investigator: Rachel B. Issaka, MD, MAS — Fred Hutch/University of Washington Cancer Consortium
  • Study coordinator: Rachel B. Issaka, MD, MAS
  • Email: rissaka@fredhutch.org
  • Phone: 206-667-1447

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.